Drug Availability Update
Further to DrugAlert Volume 281, HPS Pharmacies wish to give notice that stocks of all brands of remifentanil registered for use in Australia have been exhausted.
HPS Pharmacies are pleased to announce that limited supplies of internationally registered products may now be accessed. However, the anticipated turnaround time is at least 30 days. Access will be under the Special Access Scheme for immediate supply to seriously ill patients, pending completion and return of the Category A SAS form by the medical practitioner. Non urgent supplies require completion of a Category B form, and approval by the TGA prior to use.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.